NXTC
NextCure, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
NextCure, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
NextCure, Inc.
6.18
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Ikarian CapitalIkarian Capital | $461,284 | 16.61% | +20.98% | |
| 2 | Adage Capital Partners GPAdage Capital Partners GP | $443,523 | 15.97% | new | |
| 3 | Sofinnova InvestmentsSofinnova | $356,246 | 12.82% | 0.00% | |
| 4 | Renaissance TechnologiesRenaissance Technologies | $273,923 | 9.86% | +182.82% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $250,947 | 9.03% | −2.26% | |
| 6 | Millennium ManagementMillennium | $140,979 | 5.07% | new | |
| 7 | Boothbay Fund ManagementBoothbay Fund | $135,499 | 4.88% | +21.65% | |
| 8 | Squadron Capital ManagementSquadron | $103,142 | 3.71% | −75.67% | |
| 9 | Verdad AdvisersVerdad | $96,722 | 3.48% | +40.73% | |
| 10 | PfizerPfizer | $72,967 | 2.63% | −71.08% | |
| 11 | Affinity Asset AdvisorsAffinity Asset | $67,136 | 2.42% | −82.65% | |
| 12 | BlackRockBlackRockindex-like | $59,757 | 2.15% | +34.38% | |
| 13 | HRT FinancialHRT Financial | $58,000 | 2.09% | new | |
| 14 | Jane Street GroupJane Street | $52,360 | 1.88% | new | |
| 15 | Geode Capital ManagementGeodeindex-like | $47,855 | 1.72% | −3.82% | |
| 16 | Cardiff Park AdvisorsCardiff Park | $34,933 | 1.26% | 0.00% | |
| 17 | Acadian Asset ManagementAcadian | $30,000 | 1.08% | 0.00% | |
| 18 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $25,814 | 0.93% | +0.74% | |
| 19 | Delaware Management HoldingsDelaware | $20,000 | 0.72% | new | |
| 20 | Virtu FinancialVirtu Financial | $18,000 | 0.65% | new | |
| 21 | Diadema PartnersDiadema Partners | $12,387 | 0.45% | new | |
| 22 | BarclaysBarclays | $9,162 | 0.33% | +1.78% | |
| 23 | Persistent Asset PartnersPersistent Asset Partners | $3,170 | 0.11% | new | |
| 24 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $2,781 | 0.10% | new | |
| 25 | UBS GroupUBS | $951 | 0.03% | +75.74% |
30 managers report $2.8M of NextCure on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; Ikarian Capital is largest at 16.61%.
No implied move.
No implied move.
Expected move
No implied move.